Epistatically Interacting Substitutions Are Enriched during Adaptive Protein Evolution

English version České info

Mutations can fix during evolution for two reasons:
they can be beneficial and fix for adaptive reasons, or they can be neutral or deleterious and fix solely by chance. Most studies focus on adaptation, where the evolving population is increasing in fitness due to a new selection pressure. Such studies have found an important evolutionary role for epistasis, the phenomenon where the effect of one mutation depends on another mutation. But adaptation only accounts for a fraction of overall evolutionary change. Here we investigate whether epistasis is as common during non-adaptive as adaptive evolution. We do this by comparing the same protein from human and swine influenza. Human influenza is constantly adapting to escape from the immunity that people acquire from previous influenza infections. But swine influenza is under less pressure to escape from acquired immunity since pigs have shorter lifetimes and are less likely to be infected with influenza multiple times. We find that epistasis is less common during the evolution of the swine influenza protein than its human influenza counterpart. Overall, our results suggest that mutations that interact via epistasis are more likely to fix during adaptive evolution.

Vyšlo v časopise: Epistatically Interacting Substitutions Are Enriched during Adaptive Protein Evolution. PLoS Genet 10(5): e32767. doi:10.1371/journal.pgen.1004328
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004328

Souhrn

Zdroje

1. ChouHH, ChiuHC, DelaneyNF, SegreD, MarxCJ (2011) Diminishing Returns Epistasis Among Beneficial Mutations Decelerates Adaptation. Science 332: 1190–1192.

2. BlountZD, BorlandCZ, LenskiRE (2008) Historical contingency and the evolution of a key innovation in an experimental population of Escherichia coli. Proc Natl Acad Sci U S A 105: 7899–7906.

3. KhanAI, DinhDM, SchneiderD, LenskiRE, CooperTF (2011) Negative Epistasis Between Beneficial Mutations in an Evolving Bacterial Population. Science 332: 1193–1196.

4. SchenkMF, SzendroIG, SalverdaML, KrugJ, de VisserJA (2013) Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene. Mol Biol Evol 30: 1779–1787.

5. WeinreichDM, DelaneyNF, DepristoMA, HartlDL (2006) Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312: 111–114.

6. BeadleBM, ShoichetBK (2002) Structural bases of stability-function tradeoffs in enzymes. J Mol Biol 321: 285–296.

7. BershteinS, SegalM, BekermanR, TokurikiN, TawfikDS (2006) Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein. Nature 444: 929–932.

8. OrtlundEA, BridghamJT, RedinboMR, ThorntonJW (2007) Crystal structure of an ancient protein: evolution by conformational epistasis. Science 317: 1544–1548.

9. BridghamJT, OrtlundEA, ThorntonJW (2009) An epistatic ratchet constrains the direction of glucocorticoid receptor evolution. Nature 461: 515–519.

10. BloomJD, LabthavikulST, OteyCR, ArnoldFH (2006) Protein stability promotes evolvability. Proc Natl Acad Sci U S A 103: 5869–5874.

11. BartonNH (2000) Genetic hitchhiking. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences 355: 1553–1562.

12. ChenRB, HolmesEC (2010) Hitchhiking and the Population Genetic Structure of Avian Influenza Virus. Journal of molecular evolution 70: 98–105.

13. Kimura M (1983) The Neutral Theory of Molecular Evolution. Cambridge, U.K.: Cambridge University Press.

14. KingJL, JukesTH (1969) Non-Darwinian evolution. Science 164: 788–798.

15. LangGI, RiceDP, HickmanMJ, SodergrenE, WeinstockGM, et al. (2013) Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations. Nature 500: 571–574.

16. LynchM (2007) The frailty of adaptive hypotheses for the origins of organismal complexity. Proc Natl Acad Sci U S A 104 Suppl 1: 8597–8604.

17. NeiM (2005) Selectionism and neutralism in molecular evolution. Mol Biol Evol 22: 2318–2342.

18. SiderakiV, HuangW, PalzkillT, GilbertHF (2001) A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. Proc Natl Acad Sci U S A 98: 283–288.

19. WangX, MinasovG, ShoichetBK (2002) Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J Mol Biol 320: 85–95.

20. CovertAW3rd, LenskiRE, WilkeCO, OfriaC (2013) Experiments on the role of deleterious mutations as stepping stones in adaptive evolution. Proc Natl Acad Sci U S A 110: E3171–3178.

21. DraghiJA, ParsonsTL, PlotkinJB (2011) Epistasis increases the rate of conditionally neutral substitution in an adapting population. Genetics 187: 1139–1152.

22. DraghiJA, PlotkinJB (2013) Selection biases the prevalence and type of epistasis along adaptive trajectories. Evolution; international journal of organic evolution 67: 3120–3131.

23. SzendroIG, SchenkMF, FrankeJ, KrugJ, de VisserJAGM (2013) Quantitative analyses of empirical fitness landscapes. J Stat Mech 2013: P01005 doi:10.1088/1742-5468/2013/01/P01005

24. PortelaA, DigardP (2002) The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol 83: 723–734.

25. YeQ, KrugRM, TaoYJ (2006) The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 444: 1078–1082.

26. SmithDJ, LapedesAS, de JongJC, BestebroerTM, RimmelzwaanGF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371–376.

27. RambautA, PybusOG, NelsonMI, ViboudC, TaubenbergerJK, et al. (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453: 615–619.

28. GerhardW, YewdellJ, FrankelME, WebsterR (1981) Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290: 713–717.

29. WileyDC, WilsonIA, SkehelJJ (1981) Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289: 373–378.

30. RimmelzwaanGF, BoonAC, VoetenJT, BerkhoffEG, FouchierRA, et al. (2004) Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus Res 103: 97–100.

31. BerkhoffEG, BoonAC, NieuwkoopNJ, FouchierRA, SintnicolaasK, et al. (2004) A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol 78: 5216–5222.

32. BerkhoffEG, Geelhoed-MierasMM, FouchierRA, OsterhausAD, RimmelzwaanGF (2007) Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones. J Gen Virol 88: 530–535.

33. ValkenburgSA, RutiglianoJA, EllebedyAH, DohertyPC, ThomasPG, et al. (2011) Immunity to seasonal and pandemic influenza A viruses. Microbes and infection/Institut Pasteur 13: 489–501.

34. GongLI, SuchardMA, BloomJD (2013) Stability-mediated epistasis constrains the evolution of an influenza protein. eLife 2: e00631.

35. RenardC, HartE, SehraH, BeasleyH, CoggillP, et al. (2006) The genomic sequence and analysis of the swine major histocompatibility complex. Genomics 88: 96-+.

36. AdamsEJ, ParhamP (2001) Species-specific evolution of MHC class I genes in the higher primates. Immunological Reviews 183: 41–64.

37. SheerarMG, EasterdayBC, HinshawVS (1989) Antigenic conservation of H1N1 swine influenza viruses. J Gen Virol 70 (Pt 12) 3297–3303.

38. VincentAL, MaW, LagerKM, JankeBH, RichtJA (2008) Swine influenza viruses a North American perspective. Advances in virus research 72: 127–154.

39. VincentAL, LagerKM, MaW, LekcharoensukP, GramerMR, et al. (2006) Evaluation of hemagglutinin subtype 1 swine influenza viruses from the United States. Veterinary microbiology 118: 212–222.

40. GartenRJ, DavisCT, RussellCA, ShuB, LindstromS, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197–201.

41. LuohSM, McGregorMW, HinshawVS (1992) Hemagglutinin mutations related to antigenic variation in H1 swine influenza viruses. J Virol 66: 1066–1073.

42. NobleS, McGregorMS, WentworthDE, HinshawVS (1993) Antigenic and genetic conservation of the haemagglutinin in H1N1 swine influenza viruses. J Gen Virol 74 (Pt 6) 1197–1200.

43. WeiCJ, BoyingtonJC, DaiK, HouserKV, PearceMB, et al. (2010) Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci Transl Med 2: 24ra21.

44. BedfordT, SuchardMA, LemeyP, DudasG, GregoryV, et al. (2013) Integrating influenza antigenic dynamics with molecular evolution. Elife 3: e01914 doi:10.7554/eLife.01914

45. dos ReisM, HayAJ, GoldsteinRA (2009) Using non-homogeneous models of nucleotide substitution to identify host shift events: application to the origin of the 1918 ‘Spanish’ influenza pandemic virus. Journal of molecular evolution 69: 333–345.

46. MorensDM, TaubenbergerJK, FauciAS (2009) The persistent legacy of the 1918 influenza virus. N Engl J Med 361: 225–229.

47. Brockwell-StaatsC, WebsterRG, WebbyRJ (2009) Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza and other respiratory viruses 3: 207–213.

48. TaubenbergerJK, KashJC (2010) Influenza virus evolution, host adaptation, and pandemic formation. Cell host & microbe 7: 440–451.

49. MininVN, SuchardMA (2008) Counting labeled transitions in continuous-time Markov models of evolution. Journal of mathematical biology 56: 391–412.

50. O'BrienJD, MininVN, SuchardMA (2009) Learning to count: robust estimates for labeled distances between molecular sequences. Mol Biol Evol 26: 801–814.

51. DrummondAJ, SuchardMA, XieD, RambautA (2012) Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 29: 1969–1973.

52. BhattS, HolmesEC, PybusOG (2011) The genomic rate of molecular adaptation of the human influenza A virus. Mol Biol Evol 28: 2443–2451.

53. DiBrinoM, ParkerKC, MarguliesDH, ShiloachJ, TurnerRV, et al. (1995) Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population. Biochemistry 34: 10130–10138.

54. VoetenJT, BestebroerTM, NieuwkoopNJ, FouchierRA, OsterhausAD, et al. (2000) Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 74: 6800–6807.

55. AssarssonE, BuiHH, SidneyJ, ZhangQ, GlennJ, et al. (2008) Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 82: 12241–12251.

56. AlexanderJ, BilselP, del GuercioMF, Marinkovic-PetrovicA, SouthwoodS, et al. (2010) Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus. Human immunology 71: 468–474.

57. CheungYK, ChengSC, KeY, XieY (2012) Human immunogenic T cell epitopes in nucleoprotein of human influenza A (H5N1) virus. Hong Kong medical journal 18 Suppl 2: 17–21.

58. VitaR, ZarebskiL, GreenbaumJA, EmamiH, HoofI, et al. (2010) The immune epitope database 2.0. Nucleic Acids Res 38: D854–862.

59. SidneyJ, PetersB, FrahmN, BranderC, SetteA (2008) HLA class I supertypes: a revised and updated classification. BMC immunology 9: 1.

60. da SilvaJ, HughesAL (1998) Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1). Mol Biol Evol 15: 1259–1268.

61. HertzT, NolanD, JamesI, JohnM, GaudieriS, et al. (2011) Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. J Virol 85: 1310–1321.

62. BaoY, BolotovP, DernovoyD, KiryutinB, ZaslavskyL, et al. (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82: 596–601.

63. KrasnitzM, LevineAJ, RabadanR (2008) Anomalies in the influenza virus genome database: new biology or laboratory errors? J Virol 82: 8947–8950.

64. StamatakisA (2006) RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22: 2688–2690.

65. DrummondAJ, RambautA (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC evolutionary biology 7: 214.

66. JonesDT, TaylorWR, ThorntonJM (1992) The rapid generation of mutation data matrices from protein sequences. Computer applications in the biosciences : CABIOS 8: 275–282.

67. BloomJD, GongLI, BaltimoreD (2010) Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272–1275.

68. BloomJD, NayakJS, BaltimoreD (2011) A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase. PLoS ONE 6: e22201.

69. HoffmannE, NeumannG, KawaokaY, HobomG, WebsterRG (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97: 6108–6113.